ID: ALA3580666

Max Phase: Preclinical

Molecular Formula: C13H13NO4

Molecular Weight: 247.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)[C@H](C)N1C(=O)c2ccccc2C1=O

Standard InChI:  InChI=1S/C13H13NO4/c1-3-18-13(17)8(2)14-11(15)9-6-4-5-7-10(9)12(14)16/h4-8H,3H2,1-2H3/t8-/m0/s1

Standard InChI Key:  GGAXLKHQCAECFL-QMMMGPOBSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 247.25Molecular Weight (Monoisotopic): 247.0845AlogP: 1.23#Rotatable Bonds: 3
Polar Surface Area: 63.68Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.47CX LogD: 1.47
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.60Np Likeness Score: -0.93

References

1. Coelho LCD, Cardoso MVdO, Moreira DRM, Gomes PATdM, Cavalcanti SMT, Oliveira AR, Filho GBdO, Siqueira LRPd, Barbosa MdO, Borba EFdO, Silva TGd, Kaskow B, Karimi M, Abraham LJ, Leite ACL.  (2014)  Novel phthalimide derivatives with TNF- and IL-1 expression inhibitory and apoptotic inducing properties,  (6): [10.1039/C4MD00070F]

Source